首页> 外文期刊>International Journal of Nanomedicine >Paclitaxel/IR1061-Co-Loaded Protein Nanoparticle for Tumor-Targeted and pH/NIR-II-Triggered Synergistic Photothermal-Chemotherapy
【24h】

Paclitaxel/IR1061-Co-Loaded Protein Nanoparticle for Tumor-Targeted and pH/NIR-II-Triggered Synergistic Photothermal-Chemotherapy

机译:紫杉醇/ IR1061-共同装载的蛋白纳米粒子,用于肿瘤靶向和pH / NIR-II-触发协同感应光热化疗

获取原文
           

摘要

Purpose: The aim of this study was to develop an “all-in-one” nanoplatform that integrates at the second near-infrared (NIR-II) region dye IR1061 and anticancer drug paclitaxel (PTX) into an apoferritin (AFN) nanocage (IR-AFN@PTX). Simultaneously, folic acid (FA), tumor target molecule, was conjugated onto IR-AFN@PTX to be IR-AFN@PTX-FA for tumor-targeted and pH/NIR-II-triggered synergistic photothermal-chemotherapy. Methods: IR1061 was firstly reacted with PEG and then conjugated with AFN to be IR-AFN. Then, FA was conjugated onto the surface of IR-AFN to be IR-AFN-FA. At last, PTX was incorporated into IR-AFN-FA to fabricate a nanoplatform IR-AFN@PTX-FA. The NIR-II photothermal properties and pH/NIR-II triggered drug release were evaluated. The ability of IR-AFN@PTX-FA to target tumors was estimated using optical bioluminescence. In vitro and in vivo synergistic therapeutic effects of pH/NIR-II-triggered and tumor-targeted photothermal-chemotherapy were investigated in 4T1 tumor model. Results: IR-AFN@PTX-FA showed excellent water solubility and physiological stability, which significantly enhanced the solubility of both IR1061 and PTX. After 5 min of laser irradiation at 1064 nm, IR-AFN@PTX-FA exhibited an effective photothermal effect compared with laser irradiation at 808 nm, even when blocked with 0.6 cm thick chicken breast. Cellular uptake experiments showed IR-AFN@PTX-FA utilized clathrin-mediated and caveolae-mediated endocytosis pathways to enter 4T1 cells, and was then delivered by the endosome to the lysosome. NIR-II laser irradiation and pH could synergistically trigger PTX release, inducing significant tumor inhibition in vitro and in vivo. Conclusion: As a novel “all-in-one” nanoplatform, IR-AFN@PTX-FA was found to selectively target tumors and showed very efficient NIR-II photothermal effects and pH/NIR-II triggered drug release effects, showing a remarkable, synergistic photothermal-chemotherapy effect.
机译:目的:本研究的目的是开发一种“一体化”纳米片,其在第二次近红外(NIR-II)区染料IR1061和抗癌药物紫杉醇(PTX)中整合到Apoferritin(AFN)纳米中( IR-AFN @ PTX)。同时,叶酸(FA),肿瘤靶分子被缀合到IR-AFN @ PTX上,以IR-AFN @ PTX-FA用于肿瘤靶向和pH / NIR-II-触发协同感应光热化学疗法。方法:IR1061首先用PEG反应,然后与AFN缀合以IR-AFN。然后,将Fa缀合到IR-AFN的表面上是IR-AFN-FA。最后,PTX被纳入IR-AFN-FA,以制造纳米片IR-AFN @ PTX-FA。评价NIR-II光热性能和pH / NIR-II触发的药物释放。使用光学生物发光估计IR-AFN @ PTX-FA至靶肿瘤的能力。在4T1肿瘤模型中研究了pH / Nir-II触发和肿瘤靶向光热化学疗法的体外和体内协同疗效。结果:IR-AFN @ PTX-FA显示出优异的水溶性和生理稳定性,其显着增强了IR1061和PTX的溶解度。在1064nm的激光照射5分钟后,与808nm的激光照射相比,IR-AFN @ PTX-FA表现出有效的光热效应,即使在含有0.6cm厚的鸡胸肉时,也表现出808nm的激光照射。蜂窝摄取实验显示IR-AFN @ PTX-FA利用克拉仑介导和Caveolae介导的内吞作用以进入4T1细胞,然后通过内体递送至溶酶体。 NIR-II激光辐照和pH可以协同触发PTX释放,在体外和体内诱导显着的肿瘤抑制。结论:作为一种新颖的“一体化”纳米纳薄,发现IR-AFN @ PTX-FA选择性地靶向肿瘤并显示出非常高效的NIR-II光热效应和pH / NIR-II触发的药物释放作用,显示出显着的,协同光热 - 化疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号